PIK3CA and neoplasm: Recurrent somatic mutations of PIK3CA increase the activity of PI3Ks and the loss of phosphatase and tension homolog (PTEN, a tumor suppressor that inhibits PI3K) also can result in the overactivation of the PI3K/AKT/mTOR pathway (69).